/Investor DB

Innovatus Capital Partners — 2022 Investments

1 investments dated 2022 · listed companies and verified rows first · show all

JenaValvejenavalve.comAug 2022 · $100M

JenaValve develops transcatheter aortic valve replacement systems to treat severe aortic regurgitation and aortic stenosis.

Digital HealthHealthtechMedical DevicesIrvine, US

Hans Figulla(Director)Markus FerrariVictoria Carr-Brendel(Executive Officer, Director)David Drachman(Executive Officer, Director)John Kilcoynein

BoardArnd Kaltofen(Director)in

Co-investorsAndera PartnersBain Capital Life SciencesRosetta Capital Ltd.VI PartnersAtlas VentureGimv+5 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.